Jobbörse
Finde Jobs in deiner Nähe – ob vor Ort, hybrid oder remote.- Ähnliche Jobs zu: Scientist III
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreOxfordSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreHenley on ThamesSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreBourton on the WaterSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreRoushamSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreStratfield SayeSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Scientist - Analytical Development
Carbon 60SpekeJob Title: Scientist - Analytical Development Location: Speke, Liverpool. Contract: 12 months Salary: £17.76 p/h Hours: (37.5 hours)SRG are currently working with a global pharmaceutical manufacturer
Development Scientist
Broughton GroupUnited KingdomDevelopment Scientist Location: On-site, BB18 6JZ (Based at Earby, working across sites)Salary: £30,670 – £44,800 per annum + Excellent BenefitsHours: 40 hours per week, Monday–Friday (8-hour days, 30